- 即時微泰醫療－Ｂ
- 6.100+0.080 (+1.329%)
- 14/10/2024
- OrbiMed Advisors V Limited
- 1101(L)
- +4,500(L)
- HKD4.160(L)
- 13,541,500(L)
- 8.00
- 14/10/2024
- OrbiMed Asia Partners V, L.P.
- 1101(L)
- +4,500(L)
- HKD4.160(L)
- 13,541,500(L)
- 8.00
- 14/10/2024
- OrbiMed Asia GP V, L.P.
- 1101(L)
- +4,500(L)
- HKD4.160(L)
- 13,541,500(L)
- 8.00
- 29/07/2024
- OrbiMed Asia Partners V, L.P.
- 1001(L)
- +12,055,200(L)
- HKD3.710(L)
- 12,055,200(L)
- 7.12
- 29/07/2024
- OrbiMed Asia GP V, L.P.
- 1001(L)
- +12,055,200(L)
- HKD3.710(L)
- 12,055,200(L)
- 7.12
- 29/07/2024
- OrbiMed Advisors V Limited
- 1001(L)
- +12,055,200(L)
- HKD3.710(L)
- 12,055,200(L)
- 7.12
- 23/05/2024
- LAV Evergreen (Hong Kong) Co., Limited
- 1113(L)
- 8,545,840(L)
- 8,545,840(L)
- 5.05
- 23/05/2024
- Qiming Corporate GP V, Ltd.
- 1113(L)
- 11,925,181(L)
- 7.05
- 23/05/2024
- 施永辉
- 1711(L)
- 590,900(L)
- 0.35
- 23/05/2024
- Lilly Asia Ventures Fund GP, L.P.
- 1113(L)
- 8,545,840(L)
- 8,545,840(L)
- 5.05
- 23/05/2024
- QM32 Limited
- 1113(L)
- 11,925,181(L)
- 7.05
- 23/05/2024
- Lilly Asia Ventures Fund II, L.P.
- 1113(L)
- 8,545,840(L)
- 8,545,840(L)
- 5.05
- 23/05/2024
- LAV Corporate GP, Ltd.
- 1113(L)
- 8,545,840(L)
- 8,545,840(L)
- 5.05
- 23/05/2024
- 鄭攀
- 1711(L)
- 41,690,719(L)
- 24.63
- 23/05/2024
- Qiming Venture Partners V, L.P.
- 1113(L)
- 11,925,181(L)
- 7.05
- 23/05/2024
- Qiming GP V, L.P.
- 1113(L)
- 11,925,181(L)
- 7.05
- 28/03/2024
- CD Capital GP Ltd
- 1001(L)
- +3,000,000(L)
- 10,026,231(L)
- 5.76
- 28/03/2024
- CD Capital Healthcare FUND V, L.P.
- 1001(L)
- +3,000,000(L)
- 10,026,231(L)
- 5.76
- 28/03/2024
- CDBI Partners GP, Ltd
- 1001(L)
- +3,000,000(L)
- 10,026,231(L)
- 5.76
- 28/03/2024
- CDBI Partners Fund II, L.P.
- 1001(L)
- +3,000,000(L)
- 10,026,231(L)
- 5.76